Expert Details
Immunotherapy of Cancer, Cancer Vaccines
ID: 727532
Florida, USA
Lung cancer patients, immunotherapy and involving in Clinical Trials
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 2001 | Degree: MD | Subject: Gynecology and Obstetrics | Institution: University of Belgrade, Serbia |
| Year: 2008 | Degree: Ph.D. | Subject: Immunology, Immunotherapy of Cancer, Cancer Vaccines | Institution: University of Oslo, Norway |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 2008 to 2009 | Employer: VDesign | Title: Scientist, Immunologist | Department: |
Responsibilities: |
|||
| Years | Employer | Title | Department |
| Years: 2007 to 2008 | Employer: University of Florida | Title: PostDoc | Department: |
Responsibilities: |
|||
| Years | Employer | Title | Department |
| Years: 2002 to 2007 | Employer: Norwegian Radium Hospital | Title: PhD Student, Medical Doctor | Department: |
Responsibilities: |
|||
| Years | Employer | Title | Department |
| Years: 1997 to 2001 | Employer: Medical Center " South Banat", Serbia | Title: Residency in Gynecology and Obstetric | Department: Gynecology and Obstetric |
Responsibilities: |
|||
| Years | Employer | Title | Department |
| Years: 1998 to 2001 | Employer: Medical Center " South Banat", Serbia | Title: General Practitionar | Department: Blood Bank |
Responsibilities: |
|||
International Experience
| Years | Country / Region | Summary |
|---|---|---|
| Years: 2001 to 2007 | Country / Region: Norway | Summary: Ph.D. in cancer field. Worked with clinical trial design and 3 Phase I/II clinical trials which were approved by Norwegian Medical Association (equivalent to FDA in USA) based on the expert's work. Performed preclinical studies and clinical studies as well. |
| Years: 2006 to 2007 | Country / Region: Norway | Summary: Worked in small private consulting company based in Oslo as Consultant for cancer patients and provided patients with information about immunotherapy, where to find departments running clinical trials and how to contact personnel. |
| Years: 2007 to 2008 | Country / Region: University of Florida, Gainesville, USA | Summary: Worked as a PostDoc in Department of Prostate Cancer, as a part of team for cancer vaccines and during that time designed clinical studies for German Biotech Company, CureVac. Expert also worked on making vaccines for number of prostate cancer patients. |
| Years: 2008 to 2009 | Country / Region: VDesign, Orlando, Florida, USA | Summary: Worked as scientist immunologist, in number of projects financed by DARPA and US Army and was responsible for project plague vaccine as well as testing immunotoxicity for ImmuneRegin, Sanofi Aventis, Merck. |
Career Accomplishments
| Associations / Societies |
|---|
| Associate Member of International Society of Cellular Therapy Member of examination committee for medical students Member of Neuroblastoma Society Associate Member of American Association for Cancer Research |
| Professional Appointments |
|---|
| Reviewer in Cancer Gene Therapy, Vaccines |
| Awards / Recognition |
|---|
| PO Master Class attendance award; Master Class in Pediatric Oncology Awarded Grants: - UNIFOR Foundations – it is a Norwegian foundation who manages over 200 funds for The University of Oslo and The University of Trondheim. - International Society for Cellular Therapy; Travel award - 5,851 USD from Gertrude and Jack Nelsons foundation for study of renal carcinoma and clinical pharmacology studies - 5,851 USD from Leif Richard Erichsen and Maren Hertzberg Erichsens foundation for Norwegian Medical Research - 1,948 USD from Foundation in memory of Henrik Homans - 4,974 USD from S. G. Foundation, Oslo - 4,291 USD from Foundation in memory of Henrik Homans - 1,948 USD from S. G. Foundation, Oslo - 4,870 USD from Aase and Knutt ophthalmology foundation - 2,925 USD from Foundation H. G. and Andrine Berg and their son Hans Gysler Berg - 1,560 USD from Otto Schultz Found |
Additional Experience
| Vendor Selection |
|---|
| Worked as immunotherapy consultant in Norway for cancer patients. |
| Marketing Experience |
|---|
| Worked in Biotech Company in Orlando and has training in immunotoxicity testing using new methods. |
Language Skills
| Language | Proficiency |
|---|---|
| Norwegian | Worked as MD and Ph.D. student for 7 yrs. |
| Croatian | Native Language |
| English | Work in USA, for 2 yrs. in high professional environment |
| Swedish, Danish | Solid knowledge in these languages. |
Fields of Expertise
antigen, antitumor drug, biological therapy, breast cancer, cancer, cancer immunology, cancer immunotherapy, cancer treatment, cervical cancer, cytotoxic T lymphocyte, human papilloma virus, immunologic adjuvant, immunology, immunotherapy, kidney cancer, leukemia, liver cancer, lung cancer, monoclonal antibody, Pap smear test, vaccine development, head and neck cancer, gastrointestinal cancer, immunopharmacology, cancer causation, uterine cancer, pancreatic cancer, laryngeal cancer, esophageal cancer, bone cancer, isotype, immunization, cluster differentiation classification system, interleukin, lytic peptide, macrophage, immunotoxin, biotechnology assessment, cyclosporin, immunosuppressive drug, immunosuppression, prostate cancer, vaccination, chemical carcinogenicity, immunofluorescence laboratory blood analyzer, immunofluorescence, immunobiology, clinical genetics, autoimmune disease, malignant melanoma, biotechnology market research, adoptive cellular immunotherapy, carcinoma, thymosin, cancerous tumor, cellular immunology, clinical immunology, cancer chemotherapeutic agent, vaccine, T lymphocyte, cellular immunity, oncology, immunoassay, gene therapy, clinical medicine, blood cell, biotechnology, antibody